Prime Medicine (PRME) Treasury Shares (2021 - 2025)

Prime Medicine's Treasury Shares history runs 5 years deep, the most recent figure standing at $3.5 million for Q4 2025.

• Quarterly Treasury Shares changed 0.0% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $3.5 million, changed 0.0% from the prior year.
• Treasury Shares was $3.5 million for Q4 2025 at Prime Medicine, roughly flat from $3.5 million in the prior quarter.
• Across five years, Treasury Shares topped out at $161.4 million in Q3 2022 and bottomed at $573394.0 in Q1 2024.
• A 5-year average of $32.9 million and a median of $3.5 million in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares slumped 99.22% — and 2025, when it jumped 505.61%.
• Prime Medicine's Treasury Shares stood at $45.7 million in 2021, then slumped by 91.61% to $3.8 million in 2022, then plunged by 76.43% to $903227.0 in 2023, then surged by 284.46% to $3.5 million in 2024, then changed by 0.0% to $3.5 million in 2025.
• Business Quant data shows PRME's Treasury Shares at $3.5 million in Q4 2025, $3.5 million in Q3 2025, and $3.5 million in Q2 2025.